India is quickly becoming a major player in the global aesthetic medicine market, which is anticipated to expand threefold to reach USD 3.02 billion by 2029. This surge is driven by the growing popularity of non-invasive treatments such as Botox and fillers, along with increasing disposable incomes and a heightened focus on health. The International Society of Aesthetic Plastic Surgery has observed a global trend towards non-surgical options, which surpassed surgical procedures in 2020. Among non-surgical treatments, botulinum toxin is the most popular, with over 9 million procedures conducted worldwide, marking a 26.1% rise. Hyaluronic acid treatments are also significant, with 4.3 million administered globally.
Currently, women make up 85.7% of the market’s consumer base, though there is a growing acceptance of aesthetic treatments among men and millennials, shifting the industry’s demographics. India’s market for aesthetic medicine is valued at approximately USD 1.62 billion, with a compound annual growth rate (CAGR) of 13.2%. Dr. Rashmi Shetty, an expert in the field, notes a changing societal attitude, saying, “These procedures are no longer considered taboo; they enhance self-esteem and overall well-being.”
